News Center

With the tenet of "Healthy China, Dedicated commitment", Linuo Pharmaceuticals increases cooperation and association with external scientific research institutes while innovating and developing independently.

Corporate News

Staff Style

Home page

2023

2023 Star Club | Linuo Pharmaceutical won the "Retail Pharmacy Popular Brand Enterprise" award!

Classification：

News

On June 17, the China Pharmaceutical Circulation Trade Conference and the Third World Pharmaceutical Retail Industry Conference (referred to as the "Third Star Conference") grandly released the "Retail Pharmacy Popular Brand Enterprise" award. Keyuan Pharmaceutical (Shenzhen Stock Exchange stock code 301281) subsidiary Linuo Pharmaceutical stood out and won this award! The purpose of this award is to discover enterprises with influence, sales force, competitiveness and attention in the field of pharmaceutical retail, to encourage products to drive brands, to lead the market with brands, and to promote the continuous upgrading of China's pharmaceutical industry on the road of high-quality development!

Since its establishment more than 20 years ago, Linuo Pharmaceutical, a subsidiary of Keyuan Pharmaceutical (Shenzhen Stock Exchange Stock Code 301281), has always adhered to the corporate purpose of serving the country through industry, pursuing excellence, serving the society, and benefiting mankind, and has worked hard to implement the "Healthy China" strategy with practical actions. Escort the national economy and the people's livelihood, and contribute to the cause of human health!